|
|
Welcome to the Winter 2004 issue of Cover Shots!
In this issue, we have included quite a variety of interesting authors and editors. Everything from the planet Earth to those that live upon it are covered here. If you would like to learn more about these titles, just click on the links below.
|
|
|
|
|
|
|
Editor-in-Chief, Encyclopedia of Social Measurement
Professor of Criminology, Sociology, and Political Economy at the University of Texas at Dallas
|
|
"In the past, social measurement was characterized by distinctions that I consider unproductive. There were distinctions between quantitative and qualitative methodologies and discipline-specific preferences. These divisions were reinforced by teaching and exclusive professional associations. Besides division within social sciences, there’s been external criticism that social scientists suffer “physics envy” and human behavior is not amenable to scientific investigation. "
Full Article: [HTML]
[PDF]
|
|
|
|
Editor-in-Chief, Encyclopedia of Modern Optics
Executive Director, Adjunct Professor of Physics
Duke University
|
|
"I think that much of what we are doing right now would fall in the area of bio photonics but we interact with Mechanical Engineers who are making optical tweezers, Electronic Engineers who are improving communications, Physicists who are looking at Quantum Information and atom optics."
Full Article: [HTML]
[PDF]
|
|
|
|
Editor-in-Chief, Encyclopedia of Geology
Professor of Applied Sedimentology in the Department of Geology, Imperial College, University of London. |
|
"When I was a lad, all you needed was a stout pair of legs, a hammer and some common sense. Now, the technology, particularly computers, has completely altered what one can do. It is quite incredible the way, nowadays, one can actually image oil and gas fields under ground and see actually where they are. As the field depletes, you can actually see the oil water contact moving up over time."
Full Article: [HTML]
[PDF]
|
|
|
|
Methods in Enzymology Series Volume Editor
Associate Professor of Biology and Assistant Investigator, HHMI
California Institute of Technology
|
|
"Because of the very nature of the disease, you are trying to kill cells that are dividing excessively, so the drugs are going to be toxic. And of course the proteasome inhibitor (Velcade) that has been approved also has its own toxicity. The trick with cancer drugs is to come up with something that is toxic for a cancer cell, but hopefully not too toxic for cells in your gut, hair follicles and stem cells that form your blood, so that you can minimize the side effects on the patient."
Full Article: [HTML]
[PDF]
|
Email this Issue to a Friend |
|
